Rethinking Migraine and Stroke Risk in Middle and Older Age

For decades, the clinical narrative surrounding migraine and stroke risk has been clear-cut, specific, and highly selective. Epidemiological data firmly established that migraine, particularly migraine with aura, represents a potent risk factor for ischemic stroke in young, female individuals under 45 years of age. In contrast, older populations were largely excluded from this paradigm. It was generally assumed that traditional cardiovascular comorbidities, such as hypertension, diabetes, hyperlipidemia, and atrial fibrillation, so completely dominated the clinical landscape in middle and late life that any independent, migraine-specific contribution faded into statistical insignificance.

New Insights From the REGARDS Cohort Study

New data published in Neurology Open Access (2026) fundamentally disrupts this historical consensus. Drawing from the large, prospective Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, investigators evaluated 11,381 middle-aged and older adults across the United States. Followed for an average of 6.4 years, the study analyzed the independent relationship between migraine history (with and without aura) and the long-term incidence of ischemic stroke. The findings challenge deep-seated clinical assumptions, revealing that migraine with aura remains an active and dangerous hazard in older age, and identifying an entirely unexpected, high-risk subpopulation: middle-aged and younger-old male adults.

Why It Matters

The Longevity of Migraine-Specific Pathophysiology

The primary takeaway from the REGARDS cohort study is that migraine with aura does not lose its stroke-conferring risk as patients grow older. In the fully adjusted statistical models, participants with a history of migraine with aura exhibited a highly significant 73% increased hazard of incident ischemic stroke compared to those without migraine (Hazard Ratio \[HR\] = 1.73; 95% Confidence Interval \[CI\], 1.12–2.65).

Crucially, this hazard persisted even after exhaustive adjustment for a comprehensive battery of traditional cardiovascular risk factors. The statistical models accounted for smoking status, measured hypertension, diabetes, dyslipidemia, body mass index (BMI), atrial fibrillation, and coronary artery disease, alongside sociodemographic factors like geographic region, education, and household income.

The fact that the hazard ratio remained elevated at 1.73 after these adjustments tells us that migraine with aura cannot be dismissed merely as a proxy for an adverse cardiovascular profile. Instead, separate, endogenous pathophysiological pathways are driving ischemic events. Several distinct mechanisms are likely at play:

• Endothelial and Microvascular Dysfunction: Lifelong alterations in nitric oxide pathways, endothelial reactivity, and systemic vascular tone appear to cause chronic microvascular damage that manifests as increased stroke susceptibility in later years.
• Cortical Spreading Depression (CSD): The electrophysiological hallmark of aura—CSD—induces prolonged hypoperfusion and localized neurogenic inflammation. Over decades, recurrent exposure to these severe hemodynamic alterations may compromise cerebrovascular tissue resilience.
• Hypercoagulability and Platelet Activation: Chronic alterations in platelet reactivity and a low-grade, persistent prothrombotic state have been documented in migraineurs with aura, facilitating localized thrombosis independent of macrovascular plaques.

Conversely, the study found no significant association between migraine without aura and incident ischemic stroke in the overall cohort (HR = 1.10; 95% CI, 0.70–1.72). This stark divergence highlights the need to differentiate between these two phenotypes. Migraine with aura represents a distinct, lifelong, systemic vasculopathy that warrants dedicated clinical attention long after a patient’s initial diagnosis.

Who It Affects

Shattering the Female-Centric Paradigm

The historical literature has consistently identified young female individuals as the primary demographic for migraine-associated stroke. The REGARDS study introduces a striking, counterintuitive shift: the highest risk of ischemic stroke was observed in male participants under the age of 72 years.

When the investigators stratified the data by age and sex using the cohort’s median age (72 years), male adults younger than 72 with a history of migraine experienced a dramatic, nearly four-fold increased risk of ischemic stroke (HR = 3.67; 95% CI, 1.96–6.88). Strikingly, within this specific subgroup, the dramatic escalation in stroke hazard was present regardless of aura status. In men under 72, migraine with aura conferred an HR of 3.44 (95% CI, 1.36–8.65), while migraine without aura conferred an HR of 3.86 (95% CI, 1.75–8.52). In contrast, no statistically significant stroke elevations were detected in female participants of any age or in older male adults ($\\ge$72 years).

This unexpected finding represents a major demographic inversion that requires careful clinical interpretation. The REGARDS investigators proposed several compelling hypotheses to explain this phenomenon:

The Menopause Protective Effect

The median age of the REGARDS analytical cohort was 72.1 years, with the youngest participant enrolling at age 52. Crucially, 98.2% of the female participants were postmenopausal at baseline. It is widely established that estrogen fluctuations drive migraine severity and endothelial instability in younger women. Following menopause, hormone levels stabilize, and a high proportion of women experience a substantial reduction in migraine frequency or total symptom resolution. This clinical stabilization may explain the complete lack of an elevated stroke hazard in the older female cohort; the hormonal driver of their vascular risk had effectively ceased decades prior.

Declining Testosterone and Male Vascular Vulnerability

While women experience vascular stabilization post-menopause, middle-aged and older men experience a progressive, age-related decline in bioavailable testosterone. Hypogonadism and rapid drops in testosterone levels in aging men have been independently linked to impaired endothelial function, arterial stiffness, and adverse cardiovascular outcomes. The intersection of a systemic migraine history with the vascular vulnerability induced by declining male androgens may create a compounding effect, driving the surge in stroke incidence observed in male participants under 72.

The Lifespan Risk Switch

This demographic pattern aligns with large-scale general population data. In studies tracking stroke across life spans, the baseline risk for ischemic stroke is shown to invert during the third decade of life, switching from being more common in young women to being more common in men, and peaking dramatically in men during their fifth decade. The REGARDS data suggest that a history of migraine actively accelerates or magnifies this natural epidemiological shift, turning middle-aged men with migraine into a highly vulnerable clinical subset.

What Changes

A New Protocol for Clinical Practice

The evidence from the REGARDS cohort directly challenges several deeply ingrained clinical habits. To translate these findings into better patient outcomes, providers must implement immediate shifts in screening, risk calculation, and preventative counseling protocols.

A. Universal Migraine History Intake Across Lifespan and Sex

Clinicians must stop treating migraine as a historical artifact relevant only to young, female patients. A thorough headache history must be standard during routine health maintenance exams for all adults, regardless of age or sex. Primary care providers must specifically document a history of migraine in male patients aged 50 to 72 years, and explicitly screen for visual aura (e.g., specific vision alterations before headache onset) in all middle-aged and older adults.

B. Advanced Risk Stratification and the Limits of Calculators

Traditional atherosclerotic cardiovascular disease (ASCVD) risk calculators do not feature an input for migraine history. As a result, standard tools will systematically underestimate stroke risk in older patients with migraine with aura, and severely underestimate risk in men under 72 with any migraine history. Clinicians should manually incorporate a history of migraine with aura or middle-aged male migraine status as an unmeasured “risk-enhancing factor” when weighing the initiation of primary preventative therapies, such as low-dose statins, antiplatelet regimens, or aggressive lifestyle changes.

C. Target Modification: Aggressive Management of Confounders

Because migraine-specific pathophysiology compounds standard cerebrovascular risks, traditional risk factors must be managed to stricter targets. In a patient with a history of migraine with aura, blood pressure should be aggressively titrated to current guideline targets, glycemic control should be stringently optimized, and a zero-tolerance policy for smoking must be enforced. Clinicians must provide highly focused prevention counseling, educating these newly identified high-risk patients on the early signs of focal neurological deficits and the critical importance of emergency care.

D. Reinterpreting Ischemic Stroke Subtypes

The REGARDS study noted a distinct, though not statistically significant (p = 0.28), divergence in ischemic stroke mechanisms by migraine status. Patients without migraine predominantly experienced cardioembolic strokes, whereas patients with migraine (with or without aura) were far more likely to experience strokes driven by small vessel disease. This alignment with microvascular and endothelial dysfunction highlights the need for targeted clinical management. When a patient with a history of migraine presents with transient neurological symptoms or an acute focal deficit, clinicians should maintain an elevated suspicion for lacunar infarcts or severe deep white matter disease, tailoring neuroimaging and downstream interventions accordingly.

Conclusion: Bridging the Evidence Gap

The REGARDS cohort provides essential clarity for a clinical area previously obscured by a lack of prospective data. By demonstrating that migraine with aura continues to drive stroke risk into advanced age, and by identifying a remarkably high-risk population in middle-aged and younger-old men, this study requires a modernization of clinical perspectives.

Providers can no longer afford to view migraine through a restrictive, age-segregated lens. Migraine is a lifelong neurovascular disorder. Identifying a history of migraine and treating it as an active variable in a patient’s overall cardiovascular risk profile is a vital, evidence-based step toward preventing devastating ischemic events in an aging population.

References

1. Sprouse Blum AS, Wilkinson KS, Sparks AD, Littenberg B, Zakai NA, Judd SE, Howard VJ, Plante TB, Flaherty ML, Sawyer RP, Sweeney FS, Cushman M. Migraine and Ischemic Stroke Risk in Middle and Older Age: The REGARDS Cohort. Neurol Open Access. 2026;2:e000107. doi:10.1212/WN9.0000000000000107.
2. Acarsoy C, Fani L, Al-Hassany L, et al. Migraine and the risk of stroke in a middle-aged and elderly population: a prospective cohort study. Cephalalgia. 2023;43(1):03331024221132008.
3. Vyas MV, Silver FL, Austin PC, et al. Stroke incidence by sex across the lifespan. Stroke. 2021;52(2):447-451.
4. Androulakis XM, Sen S, Kodumuri N, et al. Migraine age of onset and association with ischemic stroke in late life: 20-year follow-up in ARIC. Headache. 2019;59(4):556-566.